Opko Health, INC Form 4 insider transactions

Phillip Frost, along with Frost Gamma Investments Trust, reports acquiring OPKO Health shares through recent transactions.

Phillip Frost, CEO and Chairman of OPKO Health, reports the acquisition of additional shares through a series of transactions.

Director Yu Alice Lin-Tsing reports acquisition of stock options in OPKO Health, Inc.

Director John A. Paganelli of OPKO Health, Inc. acquired stock options exercisable for 30,000 shares of common stock.

Prem A. Lachman, a director at OPKO Health, Inc., reports the acquisition of stock options exercisable for 30,000 shares of common stock.

Director Richard C. Pfenniger Jr. reports receiving a stock option for 60,000 shares of OPKO Health, Inc. common stock.

Richard M. Krasno, a director at OPKO Health, Inc., reported the acquisition of a stock option for 30,000 shares of common stock.

Director Roger Medel reported the acquisition of stock options in OPKO Health, Inc. on March 28, 2024.

Phillip Frost, CEO and Chairman of OPKO Health, recently purchased 500,000 shares of the company's common stock at an average price of $0.8742.

Phillip Frost, CEO and Chairman of OPKO Health, along with Frost Gamma Investments Trust, reports purchasing 500,000 shares of OPKO Health common stock at an average price of $0.8886 on March 14, 2024.

Phillip Frost, CEO and Chairman of OPKO Health, reports the acquisition of 500,000 shares of OPKO Health common stock at an average price of $0.9275 per share.

OPKO Health's CEO, Phillip Frost, and related entities, acquired 600,000 shares of common stock at an average price of $0.9323 on March 12, 2024.

Phillip Frost, CEO and Chairman of OPKO Health, acquires 500,000 shares of common stock at an average price of $0.9923.